Table 1.
Comparison of clinical manifestations between uncomplicated cases and severe cases
| All cases | Uncomplicated | Severe | Χ 2 | P value* | |
|---|---|---|---|---|---|
| (396) | (73.74 %, 292) | (26.26 %,104) | |||
| Male to female ratio | 1.75 (252/144) | 1.92 (192/100) | 1.36 (60/44) | 2.153 | 0.155 |
| Fever > 3 days | 16.41 % (65) | 11.64 % (34) | 29.81 % (31) | 18.441 | <0.0001 |
| Oral rash | 88.38 % (350) | 89.38 %(261) | 85.58 % (89) | 1.082 | 0.291 |
| Vomiting | 45.45 % (180) | 38.70 % (113) | 64.42 % (67) | 20.468 | <0.0001 |
| Headache | 2.53 % (10) | 2.05 % (6) | 3.85 % (4) | 1.000 | 0.298 |
| Startle | 57.32 % (227) | 46.92 % (137) | 86.54 % (90) | 49.209 | <0.0001 |
| Convulsion | 1.26 % (5) | 0.68 % (2) | 2.88 %(3) | 2.976 | 0.116 |
| Myoclonus | 35.10 % (139) | 21.92 % (64) | 72.12 % (75) | 84.826 | <0.0001 |
| EV71-RNA positive in stool | 242 (61.11 %) | 143 (48.97 %) | 99 (95.19 %) | 68.933 | <0.0001 |
*Chi-squared test was used to evaluate the significant variation of clinical manifestations between uncomplicated cases and severe cases. The p value less than 0.05 was considered to be significant and marked in bold